Table 1.
Name | Accession No. | Sequences (5’-3’) | Product size (bp) | |
---|---|---|---|---|
E-cadherin for human | NM_004360 | Forward | CGAGAGCTACACGTTCACGG | 119 |
Reverse | GGGTGTCGAGGGAAAAATAGG | |||
vimentin for human | NM_003380 | Forward | AGTCCACTGAGTACCGGAGAC | 98 |
Reverse | CATTTCACGCATCTGGCGTTC | |||
N-cadherin for human | NM_001792 | Forward | TGCGGTACAGTGTAACTGGG | 123 |
Reverse | GAAACCGGGCTATCTGCTCG | |||
PD-L1 for human | NM_014143 | Forward | TGGCATTTGCTGAACGCATTT | 120 |
Reverse | TGCAGCCAGGTCTAATTGTTTT | |||
SREBP-1 for human | NM_001005291 | Forward | CGGAACCATCTTGGCAACAGT | 141 |
Reverse | CGCTTCTCAATGGCGTTGT | |||
GAPDH for rat | NM_001256799 | Forward | ACAACTTTGGTATCGTGGAAGG | 101 |
Reverse | GCCATCACGCCACAGTTTC |